Advertising & Promotion of Drugs Part II (Update)

Production Date: February 14, 2017 Practice Areas: Health Care Law and Science & Technology Law Estimated Length: 3875 minutes


$ 59 Health Care Law and Science & Technology Law In Stock

Scientific innovation and business concerns can easily become entangled in the U.S. regulatory framework for the pre-approval promotion of drug and medical devices. Once drugs and devices have been approved, however, promotional-related compliance concerns do not become any less complex.

The second course in this three-part series, led by attorney Dominck DiSabatino and regulatory expert Jennifer Stohlmann, examines three important areas of drug and medical device law in the United States: pre-approval promotion, direct to consumer advertising, and off-label promotion.

Learning Objectives: 

  1. Understand pre-approval promotion
  2. Examine the legal restrictions on what can be said in the pre-approval stage

  3. Discuss the FDA & SEC Partnership

Amy G.
Norfolk, VA

They presenters seemed very dutiful.

Lynne T.
Minneapolis, MN

Thank you!

William S.
Belmont, NC

Great course. Thank you!